Ali Behbahani
Board Member
CRISPR Therapeutics AG (CRSP)Board Member
Adaptimmune Therapeutics PLC (ADAPY)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ali Behbahani
Ali Behbahani is recorded as Board Member at CRISPR Therapeutics AG (CRSP) and Board Member at Adaptimmune Therapeutics PLC (ADAPY). Ali Behbahani was last confirmed as Board Member at Monte Rosa Therapeutics, Inc. (GLUE) in a filing dated April 26, 2024. Ali Behbahani was last confirmed as Board Member at Black Diamond Therapeutics, Inc. (BDTX) in a filing dated April 18, 2025. Earlier roles on record: Board Member at Arcellx, Inc. until April 28, 2026 and Board Member at CVRx, Inc. (CVRX) until September 2, 2024. CVRx, Inc. reported in an 8-K filed September 3, 2024 that Ali Behbahani resigned as Board, effective September 2, 2024.
“On August 27, 2024, Ali Behbahani gave notice of his intention to resign from the Board effective at the close of business on September 2, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
CRISPR Therapeutics AG (CRSP)
SEC 8-K
Current2020-06-12–present
-
Current
Start not stated–present
-
Current
Start not stated–present
-
2018-01-01–2025-04-18
Last confirmed by a filing; no departure on record
-
Arcellx, Inc.
Board Member
Proxy statement
2015-01-01–2026-04-28
-
2013-01-01–2024-09-02
-
Start not stated–2024-04-26
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Arcellx, Inc.
Board Member
2015-01-01–2026-04-28
Leadership on record at Adaptimmune Therapeutics PLC
Other people whose current roles at this company are on record from its filings.
- Adrian Rawcliffe CEO, Board Member
- David M. Mott Chairman
- Christopher Hill CFO
- William Bertrand COO
- Andrew Allen Board Member
- Andrew Allen, MD, PhD Board Member
- Andrew R. Allen Board Member
- Dr Priti Hegde Board Member
- Garry E. Menzel Board Member
- Garry Menzel Board Member
Leadership on record at CRISPR Therapeutics AG
Other people whose current roles at this company are on record from its filings.
- Samarth Kulkarni CEO
- Samarth Kulkarni, Ph.D. Chairman
- Raju Prasad CFO
- Raju Prasad, Ph.D. CFO, Chief Accounting Officer
- Julianne Bruno COO
- James R. Kasinger General Counsel
- Briggs W. Morrison Board Member
- Christian Rommel Board Member
- Christian Rommel, Ph.D. Board Member
- Douglas A. Treco Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.